Health Trials

Relapsed or Refractory Acute Lymphoblastic Leukemia

1

Review clinical trials related to Relapsed or Refractory Acute Lymphoblastic Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

The study is a Phase II, single-arm, open-label, single-dose clinical trial, and its primary objective is to evaluate the efficacy and safety of CNCT19 Cell Injection in the treatment of CD19 positive Relapsed or Refractory acute lymphoblastic leukemia.

Participants needed: 100
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Juventas Cell Therapy Ltd.Updated: Aug 8, 2025Locations: 11
Eligibility criteria

Informed consent is signed by the subject. [+14]

Active Central Nervous System (CNS) involvement by malignancy. [+29]

Read more